UK markets closed

Vor Biopharma Inc. (VOR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7800-0.0300 (-1.66%)
As of 11:50AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-120,234
-117,863
-92,094
-68,899
-43,337
Depreciation & amortisation
3,598
3,492
2,525
1,434
605
Stock-based compensation
12,375
13,362
10,695
4,315
1,342
Change in working capital
-2,793
650
-9,836
-9,185
4,316
Other working capital
-107,578
-101,361
-93,606
-73,038
-40,453
Other non-cash items
4,820
4,727
3,578
3,191
782
Net cash provided by operating activities
-106,489
-100,292
-85,144
-69,144
-36,292
Cash flows from investing activities
Investments in property, plant and equipment
-1,089
-1,069
-8,462
-3,894
-4,161
Purchases of investments
-61,428
-74,923
-123,189
-87,757
0
Sales/maturities of investments
171,000
147,000
37,560
0
-
Net cash used for investing activities
108,483
71,008
-94,091
-91,651
-4,161
Cash flows from financing activities
Common stock issued
1,234
4,578
115,975
189,198
0
Other financing activities
-
-717
-
-2,215
-
Net cash used provided by (used for) financing activities
515
2,938
117,140
232,911
82,526
Net change in cash
2,509
-26,346
-62,095
72,116
42,073
Cash at beginning of period
44,868
60,119
122,214
50,098
8,025
Cash at end of period
47,377
33,773
60,119
122,214
50,098
Free cash flow
Operating cash flow
-106,489
-100,292
-85,144
-69,144
-36,292
Capital expenditure
-1,089
-1,069
-8,462
-3,894
-4,161
Free cash flow
-107,578
-101,361
-93,606
-73,038
-40,453